China’s RemeGen nets $100m led by Lilly Asia Ventures, Lake Bleu Capital
The corpus raised will be used by the company to speed up its R&D of novel drugs, among others.
Biopharma firm Zentalis secures $85m in Series C round
The new investment took the total capital raised by Zentalis to $147 million.
Chinese oncology drug developer Tot Biopharm raises $75.2m in HK IPO
Tot Biopharm floated shares in HK under rules that allow listing of pre-profit biotech companies.
China Digest: Liking Fit closes $54m; Shenzhen Capital backs Zelgen
Smart gym operator Liking Fit has raised $54 million while biopharma firm Zelgen has raised a $62 million Series B.
Japan’s Anaeropharma Science gets $13.1m led by European VC Seventure Partners
This marks Seventure Partners' foray into Japan.
Siam Bioscience forms biopharma JV with Cuban firm, to invest $86.5m
The Thai company will own 70 per cent stake in the JV